Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Exercise Tolerance"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 220
Tytuł:
New treatments for heart failure and exercise capacity.
Autorzy:
Cohen-Solal A; Université de Paris and Inserm UMR-S 942, Paris, France.
Beauvais F; Cardiology Department, Lariboisière Hospital, AP-HP, Paris, France.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2021 Dec; Vol. 23 (12), pp. 2083-2084. Date of Electronic Publication: 2021 Nov 10.
Typ publikacji:
Editorial; Comment
MeSH Terms:
Exercise Tolerance*
Heart Failure*/therapy
Humans
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Effects of haemodynamically atrio-ventricular optimized His bundle pacing on heart failure symptoms and exercise capacity: the His Optimized Pacing Evaluated for Heart Failure (HOPE-HF) randomized, double-blind, cross-over trial.
Autorzy:
Whinnett ZI; National Heart and Lung Institute, Imperial College London, London, UK.; Imperial College Healthcare NHS Trust, London, UK.
Shun-Shin MJ; National Heart and Lung Institute, Imperial College London, London, UK.; Imperial College Healthcare NHS Trust, London, UK.
Tanner M; West Sussex Hospitals NHS Trust, West Sussex, UK.
Foley P; Great Western Hospitals NHS Foundation Trust, Swindon, UK.
Chandrasekaran B; Great Western Hospitals NHS Foundation Trust, Swindon, UK.
Moore P; West Hertfordshire Hospitals NHS Trust, Hertfordshire, UK.; Barts Health NHS Trust, London, UK.
Adhya S; Medway NHS Foundation Trust, Kent, UK.
Qureshi N; Wycombe General Hospital, High Wycombe, UK.
Muthumala A; Barts Health NHS Trust, London, UK.; North Middlesex University Hospital, London, UK.
Lane R; Royal Brompton and Harefield NHS Trust, London, UK.
Rinaldi A; Guy's and St. Thomas's NHS Foundation Trust, London, UK.
Agarwal S; Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK.
Leyva F; University Hospitals Birmingham, Birmingham, UK.
Behar J; Royal Brompton and Harefield NHS Trust, London, UK.
Bassi S; Sherwood Forest Hospitals NHS Foundation Trust, UK.
Ng A; Department of Cardiovascular Sciences, University of Leicester, Leicester, UK.
Scott P; Kings College NHS Hospital, London, UK.
Prasad R; Kettering General Hospital, Northampton, UK.
Swinburn J; Royal Berkshire NHS Foundation Trust, Reading, UK.
Tomson J; Royal Free London Foundation NHS Trust, London, UK.
Sethi A; London North West University Healthcare NHS Trust, London, UK.
Shah J; London North West University Healthcare NHS Trust, London, UK.
Lim PB; National Heart and Lung Institute, Imperial College London, London, UK.
Kyriacou A; Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
Thomas D; Morriston Hospital Regional Cardiac Centre, Wales, UK.
Chuen J; Nottingham University Hospitals NHS Trust, Nottingham, UK.
Kamdar R; Croydon NHS University Hospital, London, UK.
Kanagaratnam P; National Heart and Lung Institute, Imperial College London, London, UK.
Mariveles M; Imperial College Healthcare NHS Trust, London, UK.
Burden L; Imperial College Healthcare NHS Trust, London, UK.
March K; Imperial College Healthcare NHS Trust, London, UK.
Howard JP; National Heart and Lung Institute, Imperial College London, London, UK.
Arnold A; National Heart and Lung Institute, Imperial College London, London, UK.; Imperial College Healthcare NHS Trust, London, UK.
Vijayaraman P; Geisinger Commonwealth School of Medicine, Geisinger Heart Institute, Scranton, PA, USA.
Stegemann B; National Heart and Lung Institute, Imperial College London, London, UK.
Johnson N; Imperial College Trials Unit, Imperial College London, London, UK.
Falaschetti E; Imperial College Trials Unit, Imperial College London, London, UK.
Francis DP; National Heart and Lung Institute, Imperial College London, London, UK.
Cleland JGF; School of Health and Wellbeing, University of Glasgow, Glasgow, UK.
Keene D; National Heart and Lung Institute, Imperial College London, London, UK.; Imperial College Healthcare NHS Trust, London, UK.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2023 Feb; Vol. 25 (2), pp. 274-283.
Typ publikacji:
Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Heart Failure*
Cardiac Resynchronization Therapy*/methods
Male ; Humans ; Female ; Bundle of His ; Cross-Over Studies ; Stroke Volume ; Quality of Life ; Exercise Tolerance ; Ventricular Function, Left ; Oxygen ; Treatment Outcome ; Cardiac Pacing, Artificial/methods ; Electrocardiography/methods
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
January 2021 at a glance: focus on sex differences, acute heart failure and exercise capacity.
Autorzy:
Tomasoni D; Cardiac Catheterization Laboratory and Cardiology, Cardio-thoracic Department, Civil Hospitals; Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.
Adamo M; Cardiac Catheterization Laboratory and Cardiology, Cardio-thoracic Department, Civil Hospitals; Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.
Metra M; Cardiac Catheterization Laboratory and Cardiology, Cardio-thoracic Department, Civil Hospitals; Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2021 Jan; Vol. 23 (1), pp. 1-2.
Typ publikacji:
Journal Article
MeSH Terms:
Exercise Tolerance*
Heart Failure*
Exercise Test ; Female ; Humans ; Male ; Sex Characteristics ; Stroke Volume
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Improving physical activity and exercise capacity in heart failure. Taking the first step is always the hardest.
Autorzy:
Ambrosy AP; Department of Cardiology, Kaiser Permanente San Francisco Medical Center, San Francisco, CA, USA.; Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA.
Chioncel O; Institute of Emergency for Cardiovascular Diseases 'Professor C.C. Iliescu', University of Medicine and Pharmacy Carol Davila, Bucuresti, Romania.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2020 Sep; Vol. 22 (9), pp. 1734-1736. Date of Electronic Publication: 2020 Jul 15.
Typ publikacji:
Editorial; Research Support, Non-U.S. Gov't; Comment
MeSH Terms:
Exercise Tolerance*
Heart Failure*
Accelerometry ; Aminobutyrates ; Biphenyl Compounds ; Drug Combinations ; Enalapril ; Exercise ; Humans ; Stroke Volume ; Tetrazoles ; Valsartan
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Effects of left ventricular assist device on cardiopulmonary exercise performance.
Autorzy:
Trombara F; Centro Cardiologico Monzino, University of Milan, IRCCS, Milan, Italy.
Apostolo A; Centro Cardiologico Monzino, University of Milan, IRCCS, Milan, Italy.
Vignati C; Centro Cardiologico Monzino, University of Milan, IRCCS, Milan, Italy.; Department of Clinical Sciences and Community Health, Cardiovascular Section, University of Milano, Milan, Italy.
Naliato M; Centro Cardiologico Monzino, University of Milan, IRCCS, Milan, Italy.
Ceriani R; Centro Cardiologico Monzino, University of Milan, IRCCS, Milan, Italy.
Agostoni P; Centro Cardiologico Monzino, University of Milan, IRCCS, Milan, Italy.; Department of Clinical Sciences and Community Health, Cardiovascular Section, University of Milano, Milan, Italy.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2020 Feb; Vol. 22 (2), pp. 381-382. Date of Electronic Publication: 2019 Dec 21.
Typ publikacji:
Letter
MeSH Terms:
Exercise Tolerance*
Heart Failure*/therapy
Heart-Assist Devices*
Exercise Test ; Heart ; Humans ; Ventricular Function, Left
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Particular challenges in the use of pulmonary vasodilating therapy for patients with pulmonary hypertension secondary to left heart disease. Letter regarding the article 'Effects of sildenafil on symptoms and exercise capacity for heart failure with reduced ejection fraction and pulmonary hypertension (the SilHF study): a randomized placebo-controlled multicentre trial'.
Autorzy:
Dandel M; German Centre for Cardiovascular Research (DZHK), partner site, Berlin, Germany.; Cardio Centrum Berlin, Berlin, Germany.
Hetzer R; Cardio Centrum Berlin, Berlin, Germany.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2022 Oct; Vol. 24 (10), pp. 1990. Date of Electronic Publication: 2022 Aug 02.
Typ publikacji:
Randomized Controlled Trial; Multicenter Study; Letter; Comment
MeSH Terms:
Hypertension, Pulmonary*/etiology
Hypertension, Pulmonary*/complications
Heart Failure*/complications
Heart Failure*/drug therapy
Heart Failure*/diagnosis
Ventricular Dysfunction, Left*/complications
Humans ; Sildenafil Citrate/therapeutic use ; Stroke Volume ; Exercise Tolerance ; Double-Blind Method
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Exercise testing in heart failure with preserved ejection fraction: an appraisal through diagnosis, pathophysiology and therapy - A clinical consensus statement of the Heart Failure Association and European Association of Preventive Cardiology of the European Society of Cardiology.
Autorzy:
Guazzi M; Division of Cardiology, University of Milano School of Medicine, San Paolo Hospital, Milan, Italy.
Wilhelm M; Department of Cardiology Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Halle M; Department of Prevention and Sports Medicine, Faculty of Medicine, University Hospital 'Klinikum rechts der Isar', Technical University Munich, Munich, Germany.; DZHK (Deutsches Zentrum für Herz-Kreislauf-Forschung), partner site Munich, Munich Heart Alliance, Munich, Germany.
Van Craenenbroeck E; Research Group Cardiovascular Diseases, GENCOR, University of Antwerp, Antwerp, Belgium.; Department of Cardiology, Antwerp University Hospital, Edegem, Belgium.
Kemps H; Department of Cardiology, Máxima Medical Center, Eindhoven, The Netherlands.; Department of Industrial Design, Eindhoven University of Technology, Eindhoven, The Netherlands.
de Boer RA; University Medical Center Groningen, Department of Cardiology, University of Groningen, Groningen, The Netherlands.
Coats AJS; Warwick Medical School, University of Warwick, Coventry, UK.
Lund L; Solna, Solna, Karolinska Institutet, Stockholm, Sweden.
Mancini D; Department of Cardiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Borlaug B; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
Filippatos G; National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
Pieske B; Department of Cardiology, Charité University Medicine, Berlin, Germany.; German Centre for Cardiovascular Research (DZHK), partner site Berlin, Berlin, Germany.; German Heart Center, Berlin, Germany.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2022 Aug; Vol. 24 (8), pp. 1327-1345. Date of Electronic Publication: 2022 Jul 31.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cardiology*
Heart Failure*/diagnosis
Heart Failure*/therapy
Dyspnea/diagnosis ; Dyspnea/etiology ; Exercise Test ; Exercise Tolerance/physiology ; Humans ; Stroke Volume/physiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Effects of sildenafil on symptoms and exercise capacity for heart failure with reduced ejection fraction and pulmonary hypertension (the SilHF study): a randomized placebo-controlled multicentre trial.
Autorzy:
Cooper TJ; Stavanger University Hospital, Stavanger, Norway.
Cleland JGF; National Heart Lung Institute, Imperial College, London, UK.; Robertson Centre for Biostatistics and Glasgow Clinical Trials Unit, University of Glasgow, University Avenue, Glasgow, UK.
Guazzi M; Cardiology Department, University of Milano, San Paolo Hospital, Milan, Italy.
Pellicori P; Robertson Centre for Biostatistics and Glasgow Clinical Trials Unit, University of Glasgow, University Avenue, Glasgow, UK.; Hull University Teaching Hospitals NHS Trust, Castle Hill Hospital, Cottingham, UK.
Ben Gal T; Heart Failure Unit, Cardiology Department, Rabin Medical Center, Petah Tikva and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Amir O; Division of Cardiology, Hadassah Medical Center, Faculty of Medicine, Hebrew University Jerusalem Israel & Azrieli Faculty of Medicine, Bar-Ilan University, Zfat, Israel.
Al-Mohammad A; University of Sheffield, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, the UK, Sheffield, UK.
Clark AL; Hull University Teaching Hospitals NHS Trust, Castle Hill Hospital, Cottingham, UK.
McConnachie A; Robertson Centre for Biostatistics and Glasgow Clinical Trials Unit, University of Glasgow, University Avenue, Glasgow, UK.
Steine K; Department of Cardiology, Akershus University Hospital, Oslo, Norway.
Dickstein K; University of Bergen, Stavanger University Hospital, Stavanger, Norway.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2022 Jul; Vol. 24 (7), pp. 1239-1248. Date of Electronic Publication: 2022 Jun 06.
Typ publikacji:
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Heart Failure*/complications
Heart Failure*/drug therapy
Hypertension, Pulmonary*/etiology
Ventricular Dysfunction, Left*/complications
Aged ; Double-Blind Method ; Exercise Tolerance ; Female ; Humans ; Middle Aged ; Phosphodiesterase 5 Inhibitors/pharmacology ; Phosphodiesterase 5 Inhibitors/therapeutic use ; Quality of Life ; Sildenafil Citrate/therapeutic use ; Stroke Volume ; Ventricular Function, Left
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Exercise intolerance in heart failure: beyond mitochondrial dysfunction. Letter regarding the article 'Exercise: a molecular tool to boost muscle growth and mitochondrial performance in heart failure?'
Autorzy:
Kambic T; Cardiac Rehabilitation Unit, and Department of Research and Education, General Hospital Murska Sobota, Murska Sobota, Slovenia.
Piepoli MF; Heart Failure Unit, G. da Saliceto Hospital, Piacenza, Italy.; Institute of Life Sciences, Sant'Anna School of Advanced Studies, Pisa, Italy.
Lainscak M; Division of Cardiology, General Hospital Murska Sobota, Murska Sobota, Slovenia.; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.; Slovenian Research Agency, Ljubljana, Slovenia.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2022 May; Vol. 24 (5), pp. 910. Date of Electronic Publication: 2022 Mar 09.
Typ publikacji:
Letter; Comment
MeSH Terms:
Heart Failure*
Exercise/physiology ; Exercise Tolerance/physiology ; Humans ; Mitochondria, Muscle/metabolism ; Muscle, Skeletal ; Muscles ; Oxygen Consumption
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Skeletal muscle alterations and exercise intolerance in heart failure with preserved ejection fraction patients: ultrasonography assessment of diaphragm and quadriceps.
Autorzy:
Andriopoulou M; First Critical Care Department, Evangelismos University Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.; Department of Cardiology and Cardiac Rehabilitation, Asklepieio General Hospital, Athens, Greece.
Dimaki N; Department of Cardiology and Cardiac Rehabilitation, Asklepieio General Hospital, Athens, Greece.
Kallistratos MS; Department of Cardiology and Cardiac Rehabilitation, Asklepieio General Hospital, Athens, Greece.
Chamodraka E; Department of Cardiology and Cardiac Rehabilitation, Asklepieio General Hospital, Athens, Greece.
Jahaj E; First Critical Care Department, Evangelismos University Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Vassiliou AG; First Critical Care Department, Evangelismos University Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Giokas G; Second Department of Surgery, Aretaeion University Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Kotanidou A; First Critical Care Department, Evangelismos University Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Manolis AJ; Department of Cardiology and Cardiac Rehabilitation, Asklepieio General Hospital, Athens, Greece.
Piepoli MF; Heart Failure Unit, Cardiac Department, G. da Saliceto Hospital, Piacenza, Italy.
Filippatos G; Heart Failure Unit, Attikon University Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2022 Apr; Vol. 24 (4), pp. 729-731. Date of Electronic Publication: 2022 Mar 09.
Typ publikacji:
Letter
MeSH Terms:
Heart Failure*/diagnostic imaging
Heart Failure*/metabolism
Diaphragm/diagnostic imaging ; Diaphragm/metabolism ; Exercise Tolerance/physiology ; Humans ; Muscle, Skeletal/metabolism ; Oxygen Consumption/physiology ; Stroke Volume/physiology ; Ultrasonography
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Exercise: a molecular tool to boost muscle growth and mitochondrial performance in heart failure?
Autorzy:
Nijholt KT; Department of Cardiology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
Sánchez-Aguilera PI; Department of Cardiology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
Voorrips SN; Department of Cardiology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
de Boer RA; Department of Cardiology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
Westenbrink BD; Department of Cardiology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2022 Feb; Vol. 24 (2), pp. 287-298. Date of Electronic Publication: 2022 Jan 09.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Heart Failure*
Quality of Life*
Exercise/physiology ; Exercise Therapy ; Exercise Tolerance/physiology ; Humans ; Muscle, Skeletal
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Exercise intolerance in heart failure with preserved ejection fraction: time to scrutinize diuretic therapy?
Autorzy:
Montero D; University Heart Centre, University Hospital Zurich, Zurich, Switzerland.
Flammer AJ; University Heart Centre, University Hospital Zurich, Zurich, Switzerland.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2017 Aug; Vol. 19 (8), pp. 971-973. Date of Electronic Publication: 2017 Mar 29.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Exercise Tolerance*
Diuretics/*therapeutic use
Heart Failure/*therapy
Stroke Volume/*physiology
Ventricular Function, Left/*physiology
Heart Failure/physiopathology ; Humans
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Baseline characteristics of patients in the PARALLAX trial: insights into quality of life and exercise capacity in heart failure with preserved ejection fraction.
Autorzy:
Shah SJ; Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Cowie MR; School of Cardiovascular Medicine & Sciences, Faculty of Life Sciences & Medicine, King's College London, London, UK.
Wachter R; Clinic and Policlinic for Cardiology, University Hospital Leipzig, Leipzig, Germany.; Clinic for Cardiology and Pneumology, University Medicine Göttingen and DZHK (German Center for Cardiovascular Research), partner site Göttingen, Göttingen, Germany.
Szecsödy P; Novartis, Basel, Switzerland.
Shi V; Novartis, East Hanover, NJ, USA.
Ibram G; Novartis, East Hanover, NJ, USA.
Hu M; Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Zhao Z; Novartis, Shanghai, China.
Gong J; Novartis, East Hanover, NJ, USA.
Pieske B; Department of Internal Medicine and Cardiology, Campus Virchow Klinikum, Charité University Medicine, Berlin, Germany.; Department of Internal Medicine and Cardiology, German Heart Center; DZHK (German Center for Cardiovascular Research), partner site Berlin, Berlin, Germany.; Berlin Institute of Health, Berlin, Germany.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2021 Sep; Vol. 23 (9), pp. 1541-1551. Date of Electronic Publication: 2021 Jul 26.
Typ publikacji:
Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Heart Failure*/drug therapy
Quality of Life*
Aged ; Aged, 80 and over ; Exercise Tolerance ; Female ; Humans ; Stroke Volume ; Ventricular Function, Left
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Improving exercise tolerance and quality of life in heart failure with preserved ejection fraction - time to think outside the heart.
Autorzy:
Pandey A; Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Butler J; Department of Medicine, University of Mississippi Medical Center, Jackson, MS, USA.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2021 Sep; Vol. 23 (9), pp. 1552-1554. Date of Electronic Publication: 2021 Aug 01.
Typ publikacji:
Editorial; Comment
MeSH Terms:
Heart Failure*
Quality of Life*
Exercise Test ; Exercise Tolerance ; Humans ; Stroke Volume
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The ergoreflex: how the skeletal muscle modulates ventilation and cardiovascular function in health and disease.
Autorzy:
Aimo A; Institute of Life Sciences, Scuola Superiore Sant'Anna, Pisa, Italy.; Cardiology Department, Fondazione Toscana Gabriele Monasterio, Pisa, Italy.
Saccaro LF; Institute of Life Sciences, Scuola Superiore Sant'Anna, Pisa, Italy.
Borrelli C; Emergency Medicine Division, University Hospital of Pisa, Pisa, Italy.
Fabiani I; Institute of Life Sciences, Scuola Superiore Sant'Anna, Pisa, Italy.; Cardiology Department, Fondazione Toscana Gabriele Monasterio, Pisa, Italy.
Gentile F; Cardiology Division, University Hospital of Pisa, Pisa, Italy.
Passino C; Institute of Life Sciences, Scuola Superiore Sant'Anna, Pisa, Italy.; Cardiology Department, Fondazione Toscana Gabriele Monasterio, Pisa, Italy.
Emdin M; Institute of Life Sciences, Scuola Superiore Sant'Anna, Pisa, Italy.; Cardiology Department, Fondazione Toscana Gabriele Monasterio, Pisa, Italy.
Piepoli MF; Cardiac Unit, Guglielmo da Saliceto Hospital, Piacenza, Italy.
Coats AJS; Monash University, Melbourne, Australia.; University of Warwick, Coventry, UK.
Giannoni A; Institute of Life Sciences, Scuola Superiore Sant'Anna, Pisa, Italy.; Cardiology Department, Fondazione Toscana Gabriele Monasterio, Pisa, Italy.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2021 Sep; Vol. 23 (9), pp. 1458-1467. Date of Electronic Publication: 2021 Jul 28.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Heart Failure*/therapy
Exercise Tolerance ; Humans ; Muscle, Skeletal ; Reflex ; Respiration
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Exercise tolerance can explain the obesity paradox in patients with systolic heart failure: data from the MECKI Score Research Group.
Autorzy:
Piepoli MF; Heart Failure Unit, Cardiology Department, G da Saliceto Hospital, Piacenza, Italy.
Corrà U; Divisione di Cardiologia Riabilitativa, Fondazione Salvatore Maugeri, IRCCS, Istituto Scientifico di Veruno, Veruno, Italy.
Veglia F; Centro Cardiologico Monzino, IRCCS, Milano, Italy.
Bonomi A; Centro Cardiologico Monzino, IRCCS, Milano, Italy.
Salvioni E; Centro Cardiologico Monzino, IRCCS, Milano, Italy.
Cattadori G; Centro Cardiologico Monzino, IRCCS, Milano, Italy.; Unità Operativa Cardiologia Riabilitativa, Ospedale S.Giuseppe, Multimedica Spa, IRCCS, Milano, Italy.
Metra M; Cardiology, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Italy.
Lombardi C; Cardiology, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Italy.
Sinagra G; Cardiovascular Department, Ospedali Riuniti and University of Trieste, Trieste, Italy.
Limongelli G; Cardiologia SUN, Ospedale Monaldi (Azienda dei Colli), Seconda Università di Napoli, Napoli, Italy.
Raimondo R; Salvatore Maugeri Foundation, IRCCS, Istituto Scientifico di Tradate, Dipartimento di Medicina e Riabilitazione Cardiorespiratoria Unità Operativa di Cardiologia Riabilitativa, Tradate, Italy.
Re F; Cardiology Division, Cardiac Arrhythmia Center and Cardiomyopathies Unit, St.Camillo-Forlanini Hospital, Roma, Italy.
Magrì D; Department of Clinical and Molecular Medicine, La Sapienza University, Roma, Italy.
Belardinelli R; Cardiologia Riabilitativa, Azienda Ospedali Riuniti, Ancona, Italy.
Parati G; Department of Health Science, University of Milano Bicocca and Department of Cardiology, S.Luca Hospital, Istituto Auxologico Italiano, Milano, Italy.
Minà C; ISMETT (Mediterranean Institute for Transplantation and Advanced Specialized Therapies), Palermo, Italy.
Scardovi AB; UOC Cardiologia Ospedale S. Spirito, Roma, Italy.
Guazzi M; Department of Medical Sciences, Cardiology, IRCCS San Donato Hospital, University of Milan, San Donato Milanese, Italy.
Cicoira M; Section of Cardiology, Department of Medicine, University of Verona, Italy.
Scrutinio D; Division of Cardiology, Salvatore Maugeri Foundation, IRCCS, Institute of Cassano Murge, Bari, Italy.
Di Lenarda A; Cardiovascular Center, Health Authority no. 1, Trieste, Italy.
Bussotti M; Division of Cardiology, Salvatore Maugeri Foundation, IRCCS, Institute of Milan, Milan, Italy.
Frigerio M; Cardiologic Department 'A. De Gasperis', Ospedale Cà Granda-A.O. Niguarda, Milano, Italy.
Correale M; Department of Cardiology, University of Foggia, Foggia, Italy.
Villani GQ; Heart Failure Unit, Cardiology Department, G da Saliceto Hospital, Piacenza, Italy.
Paolillo S; IRCCS SDN Istituto di Ricerca, Napoli, Italy.
Passino C; Centro Cardiologico Monzino, IRCCS, Milano, Italy.; Gabriele Monasterio Foundation, CNR-Regione Toscana, Pisa, Italy.; Scuola Superiore S. Anna, Pisa, Italy.
Agostoni P; Centro Cardiologico Monzino, IRCCS, Milano, Italy.; Department of Clinical Sciences and Community Health, Cardiovascular Section, University of Milano, Milano, Italy.
Pokaż więcej
Corporate Authors:
MECKI Score Research Group
Źródło:
European journal of heart failure [Eur J Heart Fail] 2016 May; Vol. 18 (5), pp. 545-53.
Typ publikacji:
Journal Article
MeSH Terms:
Exercise Tolerance*
Heart Failure, Systolic/*physiopathology
Obesity/*physiopathology
Aged ; Cardiorespiratory Fitness ; Cause of Death ; Cohort Studies ; Exercise Test ; Female ; Heart Failure, Systolic/epidemiology ; Heart Failure, Systolic/mortality ; Heart Failure, Systolic/surgery ; Heart Transplantation ; Humans ; Italy/epidemiology ; Male ; Middle Aged ; Multivariate Analysis ; Obesity/epidemiology ; Oxygen Consumption ; Prognosis ; Protective Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Peripheral and pulmonary effects of inorganic nitrite during exercise in heart failure with preserved ejection fraction.
Autorzy:
Reddy YNV; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
Stewart GM; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
Obokata M; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
Koepp KE; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
Borlaug BA; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2021 May; Vol. 23 (5), pp. 814-823. Date of Electronic Publication: 2021 Feb 01.
Typ publikacji:
Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Heart Failure*
Nitrites*
Exercise Test ; Exercise Tolerance ; Humans ; Oxygen Consumption ; Stroke Volume
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Determinants and consequences of heart rate and stroke volume response to exercise in patients with heart failure and preserved ejection fraction.
Autorzy:
Wolsk E; Department of Cardiology, Herlev-Gentofte Hospital, Copenhagen, Denmark.
Kaye DM; Department of Cardiology, Alfred Hospital, Baker IDI Heart and Diabetes Research Institute, Melbourne, Australia.
Komtebedde J; Corvia Medical Inc, Tewksbury, MA, USA.
Shah SJ; Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Borlaug BA; Division of Cardiovascular Diseases, Mayo Clinic and Foundation, Rochester, MN, USA.
Burkhoff D; Cardiovascular Research Foundation, Orangeburg, NY, USA.
Kitzman DW; Department of Internal Medicine, School of Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Cleland JG; Robertson Centre for Biostatistics and Clinical Trials, University of Glasgow, Glasgow and National Heart & Lung Institute, Royal Brompton and Harefield Hospitals, Imperial College, London, UK.
Hasenfuß G; Clinic for Cardiology and Pneumology, Georg August University Goettingen, Goettingen, Germany.
Hassager C; Department of Cardiology, Rigshospitalet, Copenhagen, Denmark.
Møller JE; Department of Cardiology, Rigshospitalet, Copenhagen, Denmark.
Gustafsson F; Department of Cardiology, Rigshospitalet, Copenhagen, Denmark.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2021 May; Vol. 23 (5), pp. 754-764. Date of Electronic Publication: 2021 Mar 22.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Heart Failure*
Exercise Test ; Exercise Tolerance ; Heart Rate ; Humans ; Prospective Studies ; Stroke Volume
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Oral sucrosomial iron improves exercise capacity and quality of life in heart failure with reduced ejection fraction and iron deficiency: a non-randomized, open-label, proof-of-concept study.
Autorzy:
Karavidas A; Department of Cardiology, G. Gennimatas General Hospital, Athens, Greece.
Troganis E; Department of Cardiology, G. Gennimatas General Hospital, Athens, Greece.
Lazaros G; First Department of Cardiology, Hippokration General Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece.
Balta D; Department of Cardiology, G. Gennimatas General Hospital, Athens, Greece.
Karavidas IN; University of Thessaly Medical School, Larissa, Greece.
Polyzogopoulou E; Department of Emergency Medicine, Attikon University Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece.
Parissis J; Department of Emergency Medicine, Attikon University Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece.
Farmakis D; University of Cyprus Medical School, Nicosia, Cyprus.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2021 Apr; Vol. 23 (4), pp. 593-597. Date of Electronic Publication: 2021 Jan 22.
Typ publikacji:
Clinical Trial; Journal Article
MeSH Terms:
Anemia, Iron-Deficiency*
Heart Failure*
Exercise Tolerance ; Ferric Compounds ; Humans ; Iron ; Maltose ; Quality of Life ; Stroke Volume ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Improving exercise capacity and quality of life using non-invasive heart failure treatments: evidence from clinical trials.
Autorzy:
von Haehling S; Department of Cardiology and Pneumology, University of Göttingen Medical Center and German Center for Cardiovascular Research (DZHK), Partner Site Göttingen, Göttingen, Germany.
Arzt M; Department of Internal Medicine II, University Hospital Regensburg, Regensburg, Germany.
Doehner W; BCRT - Berlin Institute of Health Center for Regenerative Therapies, Charité - Universitätsmedizin Berlin, Berlin, Germany.; Department of Internal Medicine and Cardiology, Charité - Universitätsmedizin Berlin, Campus Virchow-Klinikum and German Center for Cardiovascular Research (DZHK), Partner Site Berlin, Berlin, Germany.
Edelmann F; Department of Internal Medicine and Cardiology, Charité - Universitätsmedizin Berlin, Campus Virchow-Klinikum and German Center for Cardiovascular Research (DZHK), Partner Site Berlin, Berlin, Germany.
Evertz R; Department of Cardiology and Pneumology, University of Göttingen Medical Center and German Center for Cardiovascular Research (DZHK), Partner Site Göttingen, Göttingen, Germany.
Ebner N; Department of Cardiology and Pneumology, University of Göttingen Medical Center and German Center for Cardiovascular Research (DZHK), Partner Site Göttingen, Göttingen, Germany.
Herrmann-Lingen C; Department of Psychosomatic Medicine and Psychotherapy, University of Göttingen Medical Center and German Center for Cardiovascular Research (DZHK), Partner Site Göttingen, Göttingen, Germany.
Garfias Macedo T; Department of Cardiology and Pneumology, University of Göttingen Medical Center and German Center for Cardiovascular Research (DZHK), Partner Site Göttingen, Göttingen, Germany.
Koziolek M; Department of Nephrology and Rheumatology, University of Göttingen Medical Center, Göttingen, Germany.
Noutsias M; Mid-German Heart Center, Division of Cardiology, Angiology and Intensive Medical Care, Department of Internal Medicine III, University Hospital Halle, Martin-Luther-University Halle, Halle (Saale), Germany.
Schulze PC; Division of Cardiology, Pneumology, Angiology and Intensive Medical Care, Department of Internal Medicine I, University Hospital Jena, Friedrich-Schiller-University Jena, Jena, Germany.
Wachter R; Klinik und Poliklinik für Kardiologie, Universitätsklinikum Leipzig, Leipzig, Germany.
Hasenfuß G; Department of Cardiology and Pneumology, University of Göttingen Medical Center and German Center for Cardiovascular Research (DZHK), Partner Site Göttingen, Göttingen, Germany.
Laufs U; Klinik und Poliklinik für Kardiologie, Universitätsklinikum Leipzig, Leipzig, Germany.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2021 Jan; Vol. 23 (1), pp. 92-113. Date of Electronic Publication: 2020 May 11.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Heart Failure*
Quality of Life*
Aminobutyrates ; Angiotensin Receptor Antagonists ; Drug Combinations ; Exercise Tolerance ; Humans ; Stroke Volume ; Tetrazoles
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 220

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies